| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |